Cargando…

Exploring DNA Methylation Profiles Altered in Cryptogenic Hepatocellular Carcinomas by High-Throughput Targeted DNA Methylation Sequencing: A Preliminary Study for Cryptogenic Hepatocellular Carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) includes cryptogenic hepatocellular carcinomas (CR-HCC) that lack a defined cause. Specific DNA methylation patterns and comparisons of the aberrant alterations in DNA methylation between CR-HCC and adjacent peritumor tissues (APTs) have not yet been report...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xin, Cheng, Ya, Yan, Liang-liang, An, Ran, Wang, Xing-yu, Wang, Heng-yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547808/
https://www.ncbi.nlm.nih.gov/pubmed/33116575
http://dx.doi.org/10.2147/OTT.S267812
_version_ 1783592498507022336
author Wang, Xin
Cheng, Ya
Yan, Liang-liang
An, Ran
Wang, Xing-yu
Wang, Heng-yi
author_facet Wang, Xin
Cheng, Ya
Yan, Liang-liang
An, Ran
Wang, Xing-yu
Wang, Heng-yi
author_sort Wang, Xin
collection PubMed
description BACKGROUND: Hepatocellular carcinoma (HCC) includes cryptogenic hepatocellular carcinomas (CR-HCC) that lack a defined cause. Specific DNA methylation patterns and comparisons of the aberrant alterations in DNA methylation between CR-HCC and adjacent peritumor tissues (APTs) have not yet been reported. METHODS: The SureSelectXT Methyl-Seq Target Enrichment System was used to sequence targeted DNA methylation in three paired CR-HCC tissues and APTs. Gene Ontology (GO) enrichment and KEGG pathway analysis were performed to investigate the DNA methylation mechanism of CR-HCC. The mRNA expression levels of HOXB-AS3, HOXB6, HOXB3, USP18, MAP3K6, TIRAP, TNNI2, SHC3, CTTN, and TFAP2A, selected from the identified signaling pathways, were evaluated by quantitative real-time PCR (qPCR). RESULTS: A total of 1728 differentially methylated regions (DMRs) were identified in tumor tissues compared with non-tumor tissues, of which 868 DMRs were hypermethylated and 860 were hypomethylated. The DMRs were mapped within 2091 DMR-associated genes (DMGs). The mRNA expression of HOXB-AS3, HOXB3, and MAP3K6 was downregulated in CR-HCC tissues compared to the APTs. However, the mRNA expression of TIRAP, SHC3, and CTTN was upregulated in the CR-HCC tissues. Differences between the mRNA expression of HOXB6, USP18, TNNI2, and TFAP2A in the CR-HCC and APTS tissues were not statistically significant. GO analysis showed that the molecular functions of “binding”, “protein binding”, and “cytoskeletal protein binding” were the main categories for the hypermethylated DMGs. The hypomethylated DMGs were mostly enriched in the molecular functions “binding”, “protein binding”, “calcium ion binding”, among others. KEGG pathway analysis showed that the hypermethylated DMGs were enriched in several pathways such as “estrogen signaling pathway”, while hypomethylated DMGs were enriched in several pathways such as “proteoglycans in cancer”, suggesting that epigenetic modifications play important roles in the cryptogenic hepatocarcinogenesis. CONCLUSION: These results provide useful information for future work to characterize the functions of epigenetic mechanisms on CR-HCC.
format Online
Article
Text
id pubmed-7547808
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-75478082020-10-27 Exploring DNA Methylation Profiles Altered in Cryptogenic Hepatocellular Carcinomas by High-Throughput Targeted DNA Methylation Sequencing: A Preliminary Study for Cryptogenic Hepatocellular Carcinoma Wang, Xin Cheng, Ya Yan, Liang-liang An, Ran Wang, Xing-yu Wang, Heng-yi Onco Targets Ther Original Research BACKGROUND: Hepatocellular carcinoma (HCC) includes cryptogenic hepatocellular carcinomas (CR-HCC) that lack a defined cause. Specific DNA methylation patterns and comparisons of the aberrant alterations in DNA methylation between CR-HCC and adjacent peritumor tissues (APTs) have not yet been reported. METHODS: The SureSelectXT Methyl-Seq Target Enrichment System was used to sequence targeted DNA methylation in three paired CR-HCC tissues and APTs. Gene Ontology (GO) enrichment and KEGG pathway analysis were performed to investigate the DNA methylation mechanism of CR-HCC. The mRNA expression levels of HOXB-AS3, HOXB6, HOXB3, USP18, MAP3K6, TIRAP, TNNI2, SHC3, CTTN, and TFAP2A, selected from the identified signaling pathways, were evaluated by quantitative real-time PCR (qPCR). RESULTS: A total of 1728 differentially methylated regions (DMRs) were identified in tumor tissues compared with non-tumor tissues, of which 868 DMRs were hypermethylated and 860 were hypomethylated. The DMRs were mapped within 2091 DMR-associated genes (DMGs). The mRNA expression of HOXB-AS3, HOXB3, and MAP3K6 was downregulated in CR-HCC tissues compared to the APTs. However, the mRNA expression of TIRAP, SHC3, and CTTN was upregulated in the CR-HCC tissues. Differences between the mRNA expression of HOXB6, USP18, TNNI2, and TFAP2A in the CR-HCC and APTS tissues were not statistically significant. GO analysis showed that the molecular functions of “binding”, “protein binding”, and “cytoskeletal protein binding” were the main categories for the hypermethylated DMGs. The hypomethylated DMGs were mostly enriched in the molecular functions “binding”, “protein binding”, “calcium ion binding”, among others. KEGG pathway analysis showed that the hypermethylated DMGs were enriched in several pathways such as “estrogen signaling pathway”, while hypomethylated DMGs were enriched in several pathways such as “proteoglycans in cancer”, suggesting that epigenetic modifications play important roles in the cryptogenic hepatocarcinogenesis. CONCLUSION: These results provide useful information for future work to characterize the functions of epigenetic mechanisms on CR-HCC. Dove 2020-10-06 /pmc/articles/PMC7547808/ /pubmed/33116575 http://dx.doi.org/10.2147/OTT.S267812 Text en © 2020 Wang et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Wang, Xin
Cheng, Ya
Yan, Liang-liang
An, Ran
Wang, Xing-yu
Wang, Heng-yi
Exploring DNA Methylation Profiles Altered in Cryptogenic Hepatocellular Carcinomas by High-Throughput Targeted DNA Methylation Sequencing: A Preliminary Study for Cryptogenic Hepatocellular Carcinoma
title Exploring DNA Methylation Profiles Altered in Cryptogenic Hepatocellular Carcinomas by High-Throughput Targeted DNA Methylation Sequencing: A Preliminary Study for Cryptogenic Hepatocellular Carcinoma
title_full Exploring DNA Methylation Profiles Altered in Cryptogenic Hepatocellular Carcinomas by High-Throughput Targeted DNA Methylation Sequencing: A Preliminary Study for Cryptogenic Hepatocellular Carcinoma
title_fullStr Exploring DNA Methylation Profiles Altered in Cryptogenic Hepatocellular Carcinomas by High-Throughput Targeted DNA Methylation Sequencing: A Preliminary Study for Cryptogenic Hepatocellular Carcinoma
title_full_unstemmed Exploring DNA Methylation Profiles Altered in Cryptogenic Hepatocellular Carcinomas by High-Throughput Targeted DNA Methylation Sequencing: A Preliminary Study for Cryptogenic Hepatocellular Carcinoma
title_short Exploring DNA Methylation Profiles Altered in Cryptogenic Hepatocellular Carcinomas by High-Throughput Targeted DNA Methylation Sequencing: A Preliminary Study for Cryptogenic Hepatocellular Carcinoma
title_sort exploring dna methylation profiles altered in cryptogenic hepatocellular carcinomas by high-throughput targeted dna methylation sequencing: a preliminary study for cryptogenic hepatocellular carcinoma
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547808/
https://www.ncbi.nlm.nih.gov/pubmed/33116575
http://dx.doi.org/10.2147/OTT.S267812
work_keys_str_mv AT wangxin exploringdnamethylationprofilesalteredincryptogenichepatocellularcarcinomasbyhighthroughputtargeteddnamethylationsequencingapreliminarystudyforcryptogenichepatocellularcarcinoma
AT chengya exploringdnamethylationprofilesalteredincryptogenichepatocellularcarcinomasbyhighthroughputtargeteddnamethylationsequencingapreliminarystudyforcryptogenichepatocellularcarcinoma
AT yanliangliang exploringdnamethylationprofilesalteredincryptogenichepatocellularcarcinomasbyhighthroughputtargeteddnamethylationsequencingapreliminarystudyforcryptogenichepatocellularcarcinoma
AT anran exploringdnamethylationprofilesalteredincryptogenichepatocellularcarcinomasbyhighthroughputtargeteddnamethylationsequencingapreliminarystudyforcryptogenichepatocellularcarcinoma
AT wangxingyu exploringdnamethylationprofilesalteredincryptogenichepatocellularcarcinomasbyhighthroughputtargeteddnamethylationsequencingapreliminarystudyforcryptogenichepatocellularcarcinoma
AT wanghengyi exploringdnamethylationprofilesalteredincryptogenichepatocellularcarcinomasbyhighthroughputtargeteddnamethylationsequencingapreliminarystudyforcryptogenichepatocellularcarcinoma